Teva Pharma (TEVA) Tops Q2 EPS by 3c, Reaffirms Guidance
Tweet Send to a Friend
Teva Pharma (NYSE: TEVA) reported Q2 EPS of $0.60, $0.03 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
